Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Yee

Pain Medicine Murrells Inlet, SC Medical Doctor

NPI 1881891059 CMS profile 221959

4040 Highway 17 Unit 104, Unit 104, Murrells Inlet, SC 29576

Open in the dashboard

General payments

$11,841

235 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brian Yee of Murrells Inlet, SC is reported in the CMS Open Payments database as having received $11,841 across 235 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $496 19
2024 General $1,540 46
2023 General $3,048 67
2022 General $1,003 24
2021 General $3,294 22
2020 General $383 10
2019 General $2,078 47

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Yee
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Brian Yee were reported at $496. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Brian Yee Pain Medicine median Middle half National median
2019 $2,078 $498 $126–$1,682 $163
2020 $383 $284 $80–$910 $114
2021 $3,294 $399 $112–$1,219 $132
2022 $1,003 $455 $137–$1,484 $149
2023 $3,048 $484 $128–$1,495 $160
2024 $1,540 $498 $131–$1,540 $164
2025 $496 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $2,703 58 payments
  2. Spinal Simplicity, LLC $2,212 6 payments
  3. Abbott Laboratories $1,853 67 payments
  4. Medtronic USA, Inc. $1,684 35 payments
  5. Nalu Medical, Inc. $688 5 payments
  6. Medtronic, Inc. $667 14 payments
  7. Nevro Corp. $636 9 payments
  8. Curonix LLC $407 6 payments
  9. Relievant Medsystems, Inc. $298 10 payments
  10. Vertos Medical, Inc. $179 6 payments
  11. Other $514 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $7,996 225 payments
  2. Travel and Lodging $2,304 9 payments
  3. Education $1,541 1 payment
Products named General payments · program years 2019–2025
  1. HA MINUTEMAN G3-R $2,212 6 payments
  2. INTELLIS $1,652 33 payments
  3. WaveWriter Alpha Prime 16 $865 41 payments
  4. Intracept $841 15 payments
  5. Nalu Neurostimulation System $688 5 payments
  6. PROCLAIM $463 14 payments
  7. ETERNA Structural Heart $453 17 payments
  8. Senza Spinal Cord Stimulation System $449 6 payments
  9. ETERNA Neuromodulation $434 20 payments
  10. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $407 6 payments
  11. Other $3,108 95 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

222

Median for Pain Management: 951

Drug cost

$2,368

Median for Pain Management: $26,034

Branded share of claims

0%

Median for Pain Management: 29.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Duloxetine Hcl Generic 108 $1,303
Nabumetone Generic 39 $358
Gabapentin Generic 30 $347
Pregabalin Generic 13 $223
Methocarbamol Generic 11 $83
Meloxicam Generic 21 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,732 Part D prescribers listed as Pain Management; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 32 billing codes

Paid by Medicare

$190,906

Medicare's payments for the services billed

Medicare patients

280

Average age 73

Services billed

1,356

170 women, 110 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 39%
Ischemic heart disease 39%
Depression 30%
Chronic kidney disease 25%
COPD 25%
Osteoporosis 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

235 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record